General Experimental Conditions
All reactions were carried out under argon atmosphere. For sensitive reactions the glassware was flame-dried under vacuum before use and flooded with argon. Solids were added under argon counterflow. Syringes and cannula were purged with argon before use.
If not otherwise indicated, chemicals were employed without further purification. All solvents were dried and distilled before use. Tetrahydrofuran (THF) was distilled from sodium/benzophenone under argon. Dichloromethane was distilled from calcium hydride under argon. Dry acetonitrile was purchased from Acros (99.5%, Extra Dry over Molecular Sieve). NMR spectra were recorded at room temperature on a Bruker DPX 300, Avance II 300 or Avance II+ 600. Both, proton and 13 C chemical shifts are reported in ppm downfield from TMS and are referenced to the non-deuterated impurities of the used solvents as internal standard: CDCl3: δ =7.28 ppm ( 1 H), δ =77.00 ppm ( 13 C). The spectra are reported using the following abbreviations to express the multiplicities: s=singulet, d=doublet, t=triplet, dd=double doublet, m=multiplet. Most 13 C NMR spectra were recorded using the DeptQ or APT sequence with complete proton decoupling. The non-trivial assignments were effected by H,H-COSY, HMQB, HMBC and NOESY spectra.
Infrared spectra (IR) were recorded at room temperature on a Paragon 100 FT-IR spectrometer or a Spectrum Two (UATR) FT-IR spectrometer (both from Perkin-Elmer).
The absorptions are given in wave numbers (cm -1 ) and are characterized by the abbreviations w (weak), middle (m) strong (s) and if necessary by br (broad).
Gas chromatography-mass spectrometry (GC-MS) was performed on an Agilent GC System, HP 6890 N Serie with Mass Selective Detector 5973 N. The used temperature program started at 50 °C and heated to 300 °C (25 °C/min; 0.7 bar; 2.7 ml/min).
High-resolution mass spectra were measured on a Finnigan MAT 900s. Low-resolution mass spectra were recorded either on a Finnigan MAT Incos 50 (EI) or a MAT 900s (ESI).
Melting points were determined with a Büchi B-545 or in open capillary tubes from Marienfeld (8.0 x 1.0 mm).
Analytical thin layer chromatography (TLC) was performed on silica coated alumina plates containing a fluorescent indicator, visualized by UV light or by using a potassium permanganate solution (0.5% solution in 1 M sodium hydroxide) followed by heating.
Flash column chromatography was conducted by using either silica gel DAVISIL®LC60A 40-63 µm from GRACE DIVISION or Allox N for column chromatography 50-200 μm, Brockmann I from Acros.
X-Ray measurements were carried out using a Bruker D8 Venture circle diffractometer.
Optical rotation was determined at 20.0 °C on a Perkin-Elmer Polarimeter 343 or a Anton Paar MCP 200 Polarimeter using a cuvette with a pathlength of 10 cm. Concentrations are given in g /100 ml of solvent.
Procedures and analytical data
2.1. (S)-tert-Butyl-5-oxopyrrolidine-2-carboxylate (16) 10 16 To a suspension of L-pyroglutamic acid 10 (50.0 g, 0.39 mol, 1.0 eq.) in t BuOAc (650 ml) was added dropwise HClO4 (12.5 ml, 70 %) and the mixture was stirred at room temperature for 48 h. After a further addition of HClO4 (12.5 ml, 70 %) stirring was continued for 48 hours.
The reaction mixture was then quenched with saturated sodium bicarbonate solution (600 ml) and extracted with ethyl acetate (3 x 300 ml). The combined organic layers were dried over Na2SO4, filtered and evaporated to dryness. 2.3. Di-tert-butyl-4-allyl-5-oxopyrrolidine-1,2-dicarboxylate (9 & cis-9)
GC-MS

To a solution of pyroglutamate 11 (5.00 g, 17.5 mmol, 1.0 eq.) in THF (50 ml) was added a Lithium hexamethyldisilazide solution (22.4 ml, 20.2 mmol, 1.2 eq., 1.1 M in THF) at -78 °C.
After 1 h TPPA (5.2 g, 17.5 mmol, 1.0 eq.) and subsequently allyl bromide (1.7 ml,
19.3 mmol, 1.1 eq.) were added. After 2 h of stirring at -78 °C the reaction mixture was quenched with saturated ammonium chloride solution (50 ml) and the aqueous layer was extracted three times with EtOAc. The combined organic layers were then washed with water and brine (250 ml), dried over Na2SO4, filtered and finally evaporated to dryness. The products were separated and purified through chromatographic purification on silica (EtOAc/CyHex = 1:4) to give white crystalline solids.
To a solution of the separated cis-alkylated pyroglutamate cis-9 (1.99 g, 6.1 mmol, 1.00 eq.)
in THF (26 ml) stirred at room temperature was then added a TBAF solution (6.5 ml, 1.06 eq., 1 M in THF) before refluxing the mixture at 85 °C for 1.5 h. The reaction was then quenched with saturated ammonium chloride solution and the aqueous layer was extracted three times with EtOAc. The combined organic layers were then washed with water and brine (300 ml), dried over Na2SO4, filtered and finally evaporated to dryness. The trans-isomer 9 was separated through chromatographic purification on silica (EtOAc/CyHex = 1:4) as a white crystalline solid and was added to the previously isolated fraction (3.36 g, 10.33 mmol, 59%).
(2S,4R)-Di-tert-butyl-4-allyl-5-oxopyrrolidine-1,2-dicarboxylate (9) 1 Isolated yield after initial α-alkylation of 11. 2 Overall yield of 9 after epimerization of cis-9 and second chromatographic separation.
M(C17H27NO5)
325.40 g/mol. To a solution of pyroglutamate 9 (0.9 g, 2.8 mmol, 1.00 eq.) in THF (15 ml) stirred at -78 °C was added a Lithium triethylborohydride solution (2.8 ml, 2.8 mmol, 1.00 eq., 1 M in THF).
Yield
GC-MS
After 2 h of stirring the reaction mixture was quenched with a saturated sodium bicarbonate solution and the aqueous layer was extracted three times with Et2O. The combined organic layers were then dried over Na2SO4, filtered and finally evaporated to dryness. After dissolving the resulting clear oil in dry MeOH (9 ml), PPTS (0.02 g, 0.08 mmol, 0.02 eq.) was 
Di-tert-butyl-(2S,4R)-4,5-diallylpyrrolidine-1,2-dicarboxylate (8)
To a solution of 0.55 g (1.61 mmol, 1.0 eq.) methoxyproline 12 in 13 ml CH2Cl2 were added 0.64 ml (4.03 mmol, 2.5 eq.) allyl-TMS at -78 °C. Afterwards, 0.85 ml (3.22 mmol, 2 eq.)
BF3·OEt2 (48 %) were added dropwise over 5 min. After 2 h of stirring at -78 °C, the reaction mixture was quenched with 5 ml of a saturated solution of NaHCO3 and the aqueous layer extracted three times with 30 ml MTBE. The combined organic layers were washed two times with a saturated solution of sodium chloride, dried over MgSO4, filtered and evaporated to dryness. After chromatographic separation of the diastereomeric mixture 
HR-MS
GC-MS m/z (%) = 210 ([M]
+ -CO2 t Bu/C3H5, 28), 154 (100), 108
t Bu/C3H5, 11), 57 (C4H9, 59).
2.6. Di-tert-butyl-(2S,3aR,7aS)-2,3,3a,4,7,7a-hexahydro-1H-indole-1,2-dicarboxylate (7)
To a solution of 0.40 g (1.14 mmol, 1.00 eq.) diallylproline 8 in 35 ml DCM was added 0.05 g (0.06 mmol, 0.05 eq.) Grubbs II-catalyst and 0.02 g (0.09 mmol, 0.08 eq.) CuI at room temperature. After stirring for 2.5 h, the solution was evaporated under reduced pressure to dryness. After chromatographic purification on silica (CyHex/EtOAc = 4:1) the hexahydroindole 7 (0.35 g, 1.08 mmol, 95%) was obtained as colourless oil. 
Di-tert-butyl-(2S,3aR,7aS)-octahydro-1H-indole-1,2-dicarboxylate (13)
To a suspension of 19 mg 10wt% Pd/C in 1 ml EtOH was added 0.2 g (0.64 mmol, 1 eq.)
hexahydroindole 7 in 7 ml EtOH. The suspension was stirred for 19 h at 24 Bar in a H2-atmosphere at room temperature. The mixture was filtered over celite using EtOAc. The solution was evaporated to dryness under reduced pressure and the octahydroindole 13
(192 mg, 0.59 mmol, 95%) product obtained as a colourless oil.
M(C18H31NO4) 325.44 g/mol.
Rf 0.60 (EtOAc/CyHex, 1:2). 
HR-MS
GC-MS
t Bu, 63), 57 (60).
13
[∝] (c = 0.550, CHCl3) = 32.7 ° (365 nm), 21.4 ° (436 nm), 13.0 ° (546 nm), 10.7 ° (579 nm), 7.7 ° (589 nm).
tert-Butyl-(2S,3aR,7aS)-octahydro-1H-indole-2-carboxylate (2a)
To a solution of 100 mg (0.308 mmol, 1 eq.) octahydroindole 13 in 1.5 ml CH2Cl2 was added dropwise 0.056 ml (0.308 mmol, 1 eq.) TMSOTf at 0 °C. After stirring for 5 min, 1.5 ml of a saturated NaHCO3 solution was added at 0 °C and the reaction mixture was stirred for another 15 min. The solution was extracted five times with DCM. The combined organic layers were dried over Na2SO4, filtered and evaporated to dryness. The Boc-deprotected octahydroindole 2a (56 mg, 0.249 mmol, 98%) was obtained as white crystalline solid.
M(C13H23NO2) 225.33 g/mol.
Rf 0.14 (EtOAc/CyHex, 1:4).
MP
101.7 °C. [∝] (c = 0.525, CHCl3) = -71.9 ° (365 nm), -38.9 ° (436 nm), -25.0 ° (546 nm), -22.9 ° (579 nm), -22.9 ° (589 nm). 
H NMR
GC-MS
tert-Butyl-(2S,3aR,7aS)-1-(((S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl)-L-
HR-MS
Nota bene:
In an initial experiment, the deprotection of 15 to 1 was conducted under harsher conditions (TFA/CH2Cl2 = 2:1; 2 h, r.t.). In this case, the isolated material contained significant amounts of the diketopiperazine 16 as a by-product, the structure of which was proven by X-ray crystal structure analysis.
Structure of compounds 2a, 1 and 16 in the crystalline State (color graphics)
From top to bottom: CCDC 1862524 (for 2a), CCDC 1896252 (for 1), and CCDC 1896253 (for 16) contain the supplementary crystallographic data for this publication. These data can be obtained free of charge from the Cambridge Crystallographic Data Centre.
